SUSRF vs LLY: Which Stock is Better?
Side-by-side comparison of Surgical Science Sweden AB (publ) and Eli Lilly & Co in 2026
SUSRF
Surgical Science Sweden AB (publ)
$2.84
LLY
Eli Lilly & Co
$927.03
Key Metrics Comparison
| Metric | SUSRF | LLY | Winner |
|---|---|---|---|
| Market Cap | $150.36M | $809.09B | LLY |
| P/E Ratio | 20.29 | 39.32 | SUSRF |
| EPS (TTM) | $0.14 | $22.99 | LLY |
| Revenue Growth | 0.1% | 0.4% | LLY |
| Gross Margin | 66.6% | 83.0% | LLY |
Analyze SUSRF
Full quant analysis
Analyze LLY
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is SUSRF or LLY a better investment?
Comparing SUSRF and LLY: Surgical Science Sweden AB (publ) has a market cap of $150.36M while Eli Lilly & Co has $809.09B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between SUSRF and LLY?
SUSRF (Surgical Science Sweden AB (publ)) and LLY (Eli Lilly & Co) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: SUSRF or LLY?
Based on P/E ratios, SUSRF trades at a lower multiple (20.3x vs 39.3x).
Which is growing faster: SUSRF or LLY?
LLY has higher revenue growth at 0.4% vs 0.1% for SUSRF.
Which company is more profitable: SUSRF or LLY?
Eli Lilly & Co (LLY) has higher gross margins at 83.0% compared to 66.6% for SUSRF.
Which is the larger company: SUSRF or LLY?
Eli Lilly & Co (LLY) is larger with a market cap of $809.09B compared to $150.36M for SUSRF.
Should I buy SUSRF or LLY in 2026?
Both SUSRF and LLY have investment merit. SUSRF trades at $2.84 while LLY trades at $927.03. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between SUSRF and LLY stock?
Key differences: Market Cap ($150.36M vs $809.09B), P/E Ratio (20.3x vs 39.3x), Revenue Growth (0.1% vs 0.4%), Gross Margin (66.6% vs 83.0%).